0R15 8884.0068 1.4156% 0R1E 9171.0 0.4381% 0M69 None None% 0R2V 254.3746 5.7691% 0QYR 1619.0 1.9521% 0QYP 436.689 -0.8652% 0RUK None None% 0RYA 1604.02 0.4396% 0RIH 190.8 0.0% 0RIH 198.5 4.0356% 0R1O 225.0 9877.8271% 0R1O None None% 0QFP None None% 0M2Z 255.4879 -0.0829% 0VSO 33.09 -7.0636% 0R1I None None% 0QZI 599.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 225.74 -0.2871%
Stay apprised, Invest wise with KALKINE!
Health care stocks can be purely defensive play in an environment of rising interest rates and economic uncertainty.
The healthcare sector is currently expanding and offering long-term success stories given the innovations at hand, new approvals falling in place with relaxed norms and prevailing positive trends globally.
While the defensive and diverse nature of the sector governs the momentum, one also needs to look at the challenges that are mainly associated with the government regulatory changes, increased competition, safety concerns, outcome of research trials, and
The growth in aging population, people living longer with chronic disease, obesity and diabetes epidemics, technological advancements, the global reach of disease, personalized medicine, among others are the demand drivers.
Normal business environment after elevated demand induced by the Covid-19 pandemic can restrict the growth prospects. The sector can also be impacted by supply chain shortage, economic recession, fluctuating exchange rate movements, among others.
UK 
AU
CA
US
NZ
Please wait processing your request...